Description:

Study Title: LEOSS: Lean European Open Survey on SARS-CoV-2 Infected Patients https://leoss.net Study Indication: COVID-19 Date: 21.03.2021 Published with permission by Prof. Dr. med. J.-J. Vehreschild. LEOSS, a multi-center cohort study, has been created to get more in-depth knowledge about the epidemiology and clinical course of patients infected with SARS-CoV-2. Initiated by the ESCMID Emerging Infections Task Force (EITaF) and the German Infectious Disease Society, and supported by all German Centers for Health Research (DZG), LEOSS has developed into an international network of contributors. Via an integrative research approach with anonymous recruitment and collection of routine data in an open science context, LEOSS is building a uniform clinical dataset and providing real-time analyses. For more information feel free to explore https://leoss.net/. This document is for ethics and palliative care details. If a text field can't be filled out, note 'ND'.

Link:
https://leoss.net
Keywords:
  1. 11/27/20 11/27/20 -
  2. 12/4/20 12/4/20 - Sarah Riepenhausen
  3. 6/29/21 6/29/21 -
Copyright Holder:
LEOSS
Uploaded on:

June 29, 2021

DOI:
To request one please log in.
License :
Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

LEOSS: Lean European Open Survey on SARS-CoV-2 Infected Patients

Ethics and palliative care details

Reasons for indicated change of therapeutic goals from life-prolonging to palliative
Progress of COVID-19
Progress of pre-existing life-limiting disease
Progress of other acute life-limiting disease
Presumed or real scarcity of resources
Other reasons for change of therapeutic goals from life-prolonging to palliative
No reasons for change of therapeutic goals from life-prolonging to palliative
Unknown reasons for change of therapeutic goals from life-prolonging to palliative
Ethics consultation
Did an ethics consultation take place
Did the patient decline specific life-prolonging measures in case of life threatening diseases?
Admission to hospital (not ICU)
Admission to intensive care unit
Intubation
Resuscitation
In which specialist palliative care setting was the patient cared for?
Specialist palliative home care
Hospital support team (palliative care consultation service)
Specialist palliative care unit
Inpatient hospice
Other
No specialist palliative care setting
Unknown
Which type of specialist palliative care did the patient receive?
Symptom control
Psychological support
Social support
Spiritual support
Support of relatives
Which type of specialist palliative care professionals were involved?
Palliative physician
Palliative care nurse
Psychologist
Chaplain/pastoral worker
Physiotherapist
Music therapist
Art therapist
Social worker
Hospice volunteers
Other specialist palliative care professionals involved
Which drugs were prescribed for symptom control (e.g. breathlessness, pain, death rattle)?
Opioids (e.g. morphine, hydromorphone, oxycodone)
Benzodiazepines (e.g. lorazepam, midazolam)
Neuroleptics (e.g. haloperidol, levomepromazine/methotrimeprazine)
Anticholinergics (e.g. hysocine butylbromide, glycopyrronium)
Other drugs for symptom control
Is data entry for this section finished?
Is data entry for this section finished?

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial